Skip to content

Source filing unavailable

Q2 2011 · —
Revenue$193.33M+8.2% vs Q2 2010+6.8% vs Q1 2011
Net Income$699.00K−95.4% vs Q2 2010−93.9% vs Q1 2011
EPS Diluted$0.02−96.0% vs Q2 2010−94.7% vs Q1 2011
Gross Profit$120,491,000+5.6%
Operating Income$8,000,000−67.5%
Operating Cash Flowderived$24,583,000+27.0%
Free Cash Flowderived$17,367,000+27.6%
Margins · derived
Gross margin62.3%−1.6 pt vs Q2 2010
Operating margin4.1%−9.6 pt vs Q2 2010
Net margin0.4%−8.1 pt vs Q2 2010

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2011Q2 2010Q2 2009
Revenue$193.33M$178.60M$165.73M
Net Income$699.00K$15.16M$11.23M
EPS Diluted$0.02$0.50$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR